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tively correlated (r¼0.413, p¼0.04).
CONCLUSIONS While a minimal deformation of the waist of the ASD
device is expected due to a relative intentional oversizing, in the
present study the observed deformation of the disks of the device was
not correlated with the deformation of the waist. Therefore potential
mechanisms for this deformation, such as mechanical tension from
adjacent structures, should be investigated in future studies.
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BACKGROUND Drug therapy (DT) for ventricular tachycardia (VT) is
not very effective and is fraught with pro-arrhythmic and other
adverse effects. Catheter ablation (CA) of VT is considered an effective
alternative to DT.
METHODS PubMed, EBSCO and Ovid databases were searched to
identify studies comparing CA and DT for the management of VT in
structural heart disease. Studies reporting outcomes of idiopathic VT
were excluded. Baseline characteristics and outcomes of recurrence of
VT and mortality were extracted from the included studies. Risk ratio
(RR) was calculated for the outcomes of recurrence of VT and mor-
tality using random effects model with 95% conﬁdence intervals (CI).
RESULTS A total of 8 studies (5 randomized studies) met our inclusion
criteria and included 1256 patients, 379 in the CA group and 877 in the
DT group. Follow up times varied from 6 months to 5 years. Heteroge-
neity was assessed by Cochcrane q statistic, which suggested low de-
gree of heterogeneity (I2¼25%). VT recurred in 36% and 54% of the CA
and DT groups, respectively. The overall RR of recurrence of VT was
0.67 (95% CI 0.51 – 0.89) in favor of the CA group and exclusion sensi-
tivity of the individual studies did not alter the above results. Subgroup
analysis including only randomized studies also showed a decreased
recurrence of VT after catheter ablation (RR 0.72, 95% CI 0.52 – 0.99).
Mortality was reported in 6 studies and mortality was signiﬁcantly
lower in the CA group compared to DT group (17% vs 42%). The overall
risk ofmortalitywas signiﬁcantly lower in theCA group (RR0.63, 95%CI
0.47 – 0.85). The decrease in mortality was driven by a single study
(Bunch et al.) Publication biaswas assessed bymeans of trim andﬁll plot
and was deemed to be minimal and moderate for the outcomes of VT
recurrence and mortality, respectively.
CONCLUSIONS The results of this meta-analysis suggest that the risk
of VT recurrence and mortality are decreased by 33% and 37%
respectively with CA of VT compared to DT.
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BACKGROUND Transcatheter closure of ostium secundum atrial septal
defect (ASD) by atrial septal occluder (ASO) device is aminimally invasive
and effective alternative to surgical repair of ostium secundum atrial
septal defect. This procedure is routinely been practiced with balloon
sizing and invasive echocardiographic assessment. The sizing balloon
usually costs around USD 600, which is not affordable for most of the
patients in our setting. Amethod of device closurewithout balloon sizing
had been described in recent past. We derived a sizing formula using our
initial results and oversized the device ranging from 4 to 6mm to
maximum ASD diameter measured by transthoracic echocardiogram.
This study was designed to evaluate the safety and effectiveness of
transcatheter closure of ostium secundum atrial septal defect without
balloon sizing or invasive echocardiographic assessment.
METHODS Medical records and followed up data of 128 patients who
underwent transcatheter closure of ostium secundum atrial septal defect
by atrial septal occluder device, from March 2009 to May 2014 were
analyzed. The abovementioned sizing formulawas used for device sizing
whereas ﬂuoroscopy and transthoracic echocardiogram were used for
device positioning and assessing the stability. This procedure was done
under local anesthesia. The patients were followed up with a periodic
clinical and echocardiographic evaluation and procedural out comes and
subsequent complications were retrospectively analyzed.
RESULTS Among 128 patients 68.8% (n¼88) were females and 31.2%
(n¼40) were males. Mean age was 34.713.9 with a range from 13 to 63
years. The mean ASD diameter according to the transthoracic echo-
cardiographic measurement was 17.85.1 mm ranging from 8mm to
30mm. Mean size of ASO device diameter was 22.65.5 mm ranging
from 12mm to 34mm. The ﬁnal success rate of the procedure was 91.4%
(n¼117) and failure rate was 8.6% (n¼11). No major complications such
as thromboembolic events, obstruction of intracardiac structures, car-
diac perforation, device embolization, device erosion and residual
shunting or deaths were reported during the procedure or within one
year follow up period.Minor complicationswere reported in 3.9% (n¼5)
of patients. With the use of above mentioned method, average cost per
patient excluding the device cost was USD 325.
CONCLUSIONS Transcatheter closure of ostium secundum ASD with
ASO device using device sizing formula and non-invasive trans-
thoracic echocardiographic assessment is a feasible, safe and cost
effective method which would be more appropriate for countries with
minimum resources for health care.
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BACKGROUND Surgical myectomy (SM) and alcohol septal ablation
(ASA) are the 2 invasive strategies used to relieve left ventricular
outﬂow tract obstruction (LVOTO) in patients with drug refractory
symptomatic hypertrophic cardiomyopathy (HCM). No randomized
